Literature DB >> 27215434

The Use of Medical Marijuana in Cancer.

Shauna M Birdsall1, Timothy C Birdsall2, Lucas A Tims2.   

Abstract

The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking. Medical marijuana is now legal, on some level, in 24 states plus the District of Columbia, yet is not legal on the federal level. This review addresses the current state of the research, including potential indications, risks and adverse effects, preliminary data on anticancer effects, as well as legal and quality issues. A summary of the clinical trials underway on medical marijuana in the oncology setting is discussed.

Entities:  

Keywords:  CBD; Cancer; Cannabidiol; Cannabinoid; Cannabis; Delta-9-THC; Delta-9-tetrahydrocannabinol; Dronabinol; Endocannabinoid; Marijuana; Nabilone; Nabiximols; Oncology; THC; Tetrahydrocannabinol

Mesh：

Substances：

Year:  2016        PMID： 27215434     DOI： 10.1007/s11912-016-0530-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  16 in total

Review 1.  An epidemiologic review of marijuana and cancer: an update.

Authors:  Yu-Hui Jenny Huang; Zuo-Feng Zhang; Donald P Tashkin; Bingjian Feng; Kurt Straif; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01       Impact factor: 4.254

2.  Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study.

Authors:  Anil A Thomas; Lauren P Wallner; Virginia P Quinn; Jeffrey Slezak; Stephen K Van Den Eeden; Gary W Chien; Steven J Jacobsen
Journal:  Urology       Date:  2014-11-01       Impact factor: 2.649

3.  An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.

Authors:  Jeremy R Johnson; Dominique Lossignol; Mary Burnell-Nugent; Marie T Fallon
Journal:  J Pain Symptom Manage       Date:  2012-11-08       Impact factor: 3.612

Review 4.  Marijuana and lung diseases.

Authors:  Manish Joshi; Anita Joshi; Thaddeus Bartter
Journal:  Curr Opin Pulm Med       Date:  2014-03       Impact factor: 3.155

5.  Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

Authors:  Russell K Portenoy; Elena Doina Ganae-Motan; Silvia Allende; Ronald Yanagihara; Lauren Shaiova; Sharon Weinstein; Robert McQuade; Stephen Wright; Marie T Fallon
Journal:  J Pain       Date:  2012-04-05       Impact factor: 5.820

6.  Inhaled medicinal cannabis and the immunocompromised patient.

Authors:  Rosa Ruchlemer; Michal Amit-Kohn; David Raveh; Lumír Hanuš
Journal:  Support Care Cancer       Date:  2014-09-13       Impact factor: 3.603

7.  Marijuana use and risk of lung cancer: a 40-year cohort study.

Authors:  Russell C Callaghan; Peter Allebeck; Anna Sidorchuk
Journal:  Cancer Causes Control       Date:  2013-07-12       Impact factor: 2.506

Review 8.  Cannabinoids as therapeutic agents in cancer: current status and future implications.

Authors:  Bandana Chakravarti; Janani Ravi; Ramesh K Ganju
Journal:  Oncotarget       Date:  2014-08-15

9.  Proapoptotic effect of endocannabinoids in prostate cancer cells.

Authors:  O Orellana-Serradell; C E Poblete; C Sanchez; E A Castellón; I Gallegos; C Huidobro; M N Llanos; H R Contreras
Journal:  Oncol Rep       Date:  2015-01-21       Impact factor: 3.906

Review 10.  The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy.

Authors:  Melvyn Weibin Zhang; Roger C M Ho
Journal:  J Addict       Date:  2015-10-11
View more
  15 in total

1.  Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State.

Authors:  Arum Kim; Christopher N Kaufmann; Roxanne Ko; Zujun Li; Benjamin H Han
Journal:  J Palliat Med       Date:  2019-03-25       Impact factor: 2.947

2.  Medical marijuana certification for patients with sickle cell disease: a report of a single center experience.

Authors:  Susanna A Curtis; Dana Lew; Jonathan Spodick; Jeanne E Hendrickson; Caterina P Minniti; John D Roberts
Journal:  Blood Adv       Date:  2020-08-25

3.  Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample.

Authors:  Elizabeth K Do; Albert J Ksinan; Sunny Jung Kim; Egidio G Del Fabbro; Bernard F Fuemmeler
Journal:  Cancer       Date:  2021-07-20       Impact factor: 6.860

Review 4.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

5.  Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use.

Authors:  Steven A Pergam; Maresa C Woodfield; Christine M Lee; Guang-Shing Cheng; Kelsey K Baker; Sara R Marquis; Jesse R Fann
Journal:  Cancer       Date:  2017-09-25       Impact factor: 6.860

Review 6.  A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.

Authors:  Melissa E Badowski
Journal:  Cancer Chemother Pharmacol       Date:  2017-08-05       Impact factor: 3.333

Review 7.  Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.

Authors:  Attila Oláh; Zoltán Szekanecz; Tamás Bíró
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 8.  A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors.

Authors:  Jesus-Eduardo Rodriguez-Almaraz; Susan Chang; Jennifer Clarke; Nancy Ann Oberheim-Bush; Jennie Taylor; Robin Buerki; Mitchel Berger; Lydia Zablotska; Iryna Lobach; Nicholas Butowski
Journal:  Neurooncol Pract       Date:  2020-04-03

Review 9.  The current state and future perspectives of cannabinoids in cancer biology.

Authors:  Paweł Śledziński; Joanna Zeyland; Ryszard Słomski; Agnieszka Nowak
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

Review 10.  Molecular Basis of Cancer Pain Management: An Updated Review.

Authors:  Ayappa V Subramaniam; Ashwaq Hamid Salem Yehya; Chern Ein Oon
Journal:  Medicina (Kaunas)       Date:  2019-09-12       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.